149 related articles for article (PubMed ID: 9839588)
21. Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.
Huang TG; Ip SM; Yeung WS; Ngan HY
Eur J Cancer; 2000 Jan; 36(2):249-56. PubMed ID: 10741285
[TBL] [Abstract][Full Text] [Related]
22. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.
Rieger KM; Little AF; Swart JM; Kastrinakis WV; Fitzgerald JM; Hess DT; Libertino JA; Summerhayes IC
Br J Cancer; 1995 Sep; 72(3):683-90. PubMed ID: 7669581
[TBL] [Abstract][Full Text] [Related]
23. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
24. The unexplained survival of cells in oral cancer: what is the role of p53?
Whyte DA; Broton CE; Shillitoe EJ
J Oral Pathol Med; 2002 Mar; 31(3):125-33. PubMed ID: 11903817
[TBL] [Abstract][Full Text] [Related]
25. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
Yu D; Liu F; Liang Z
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
[TBL] [Abstract][Full Text] [Related]
26. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
28. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
29. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
30. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
Rassidakis GZ; Thomaides A; Wang S; Jiang Y; Fourtouna A; Lai R; Medeiros LJ
Leukemia; 2005 Sep; 19(9):1663-9. PubMed ID: 15990866
[TBL] [Abstract][Full Text] [Related]
31. Allelic deletions of cell growth regulators during progression of bladder cancer.
Primdahl H; von der Maase H; Christensen M; Wolf H; Orntoft TF
Cancer Res; 2000 Dec; 60(23):6623-9. PubMed ID: 11118045
[TBL] [Abstract][Full Text] [Related]
32. Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperature-sensitive Val138 mutant.
Wang FJ
J Med Dent Sci; 1998 Jun; 45(2):141-9. PubMed ID: 11186200
[TBL] [Abstract][Full Text] [Related]
33. Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53.
Jin X; Burke W; Rothman K; Lin J
Anticancer Res; 2002; 22(2A):659-64. PubMed ID: 12014634
[TBL] [Abstract][Full Text] [Related]
34. p53 and p53-regulated genes in bladder cancer.
Crew JP; Jones A
BJU Int; 1999 Mar; 83(4):529-30. PubMed ID: 10210595
[No Abstract] [Full Text] [Related]
35. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
36. [Activator of metastasis in cancer cells, Mst1/S100A4 protein binds to tumor suppressor protein p53].
Grigorian M; Lukanidin E
Genetika; 2003 Jul; 39(7):900-8. PubMed ID: 12942774
[TBL] [Abstract][Full Text] [Related]
37. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
38. PTEN ablation in Ras(Ha)/Fos skin carcinogenesis invokes p53-dependent p21 to delay conversion while p53-independent p21 limits progression via cyclin D1/E2 inhibition.
Macdonald FH; Yao D; Quinn JA; Greenhalgh DA
Oncogene; 2014 Aug; 33(32):4132-43. PubMed ID: 24037529
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
